Peter Barnes is Margaret-Turner Warwick Professor of Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College and Honorary Consultant Physician at Royal Brompton Hospital, London.
He qualified at Cambridge and Oxford Universities (first class honours) and was appointed to his present post in 1987. He has published over 1000 peer-review papers on asthma, COPD and related topics (h-index 150) and has written or edited over 50 books. He is the 7th most highly cited researcher in the world, has been the most highly cited clinical scientist in Europe and the most highly cited respiratory researcher in the world over the last 20 years.
He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He is a member of the Scientific Committee of global guidelines on asthma (GINA) and COPD (GOLD). He also serves on the Editorial Board of over 30 journals and is currently an Associate Editor of Chest, Journal of COPD Foundation, Respiratory Editor of PLoS Medicine and Editor in Chief of Up-to-Date Pulmonary Medicine. He has given several prestigious lectures, including the Amberson Lecture at the American Thoracic Society, the Sadoul Lecture at the European Respiratory Society and the Croonian Lecture at the Royal College of Physicians, London. He has been received honorary degrees from the Universities of Ferrara (Italy), Athens (Greece), Tampere (Finland), Leuven (Belgium) and Maastricht (Netherlands). He is a NIHR Senior Investigator and was elected a Master Fellow of the American College of Chest Physicians and a member of Academia Europaea in 2012. He was President of the European Respiratory Society 2013/2014. He co-founded an Imperial spin-out company RespiVert, which was acquired by Johnson & Johnson and has developed novel inhaled treatments for COPD and severe asthma.